Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Tissue Engineered Heart Valve Market Research Report 2019-2025

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Tissue Engineered Heart Valve Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Transcatheter Heart Valves
      • 1.3.3 Tissue Heart Valves
      • 1.3.4 Mechanical Heart Valves
    • 1.4 Market Segment by Application
      • 1.4.1 Global Tissue Engineered Heart Valve Market Share by Application (2019-2025)
      • 1.4.2 Heart Surgery
      • 1.4.3 Cardiovascular Disease
      • 1.4.4 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Tissue Engineered Heart Valve Market Size
      • 2.1.1 Global Tissue Engineered Heart Valve Revenue 2014-2025
      • 2.1.2 Global Tissue Engineered Heart Valve Sales 2014-2025
    • 2.2 Tissue Engineered Heart Valve Growth Rate by Regions
      • 2.2.1 Global Tissue Engineered Heart Valve Sales by Regions 2014-2019
      • 2.2.2 Global Tissue Engineered Heart Valve Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Tissue Engineered Heart Valve Sales by Manufacturers
      • 3.1.1 Tissue Engineered Heart Valve Sales by Manufacturers 2014-2019
      • 3.1.2 Tissue Engineered Heart Valve Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Tissue Engineered Heart Valve Revenue by Manufacturers (2014-2019)
      • 3.2.2 Tissue Engineered Heart Valve Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Tissue Engineered Heart Valve Market Concentration Ratio (CR5 and HHI)
    • 3.3 Tissue Engineered Heart Valve Price by Manufacturers
    • 3.4 Key Manufacturers Tissue Engineered Heart Valve Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Tissue Engineered Heart Valve Market
    • 3.6 Key Manufacturers Tissue Engineered Heart Valve Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Transcatheter Heart Valves Sales and Revenue (2014-2019)
      • 4.1.2 Tissue Heart Valves Sales and Revenue (2014-2019)
      • 4.1.3 Mechanical Heart Valves Sales and Revenue (2014-2019)
    • 4.2 Global Tissue Engineered Heart Valve Sales Market Share by Type
    • 4.3 Global Tissue Engineered Heart Valve Revenue Market Share by Type
    • 4.4 Tissue Engineered Heart Valve Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Tissue Engineered Heart Valve Sales by Application

    6 United States

    • 6.1 United States Tissue Engineered Heart Valve Breakdown Data by Company
    • 6.2 United States Tissue Engineered Heart Valve Breakdown Data by Type
    • 6.3 United States Tissue Engineered Heart Valve Breakdown Data by Application

    7 European Union

    • 7.1 European Union Tissue Engineered Heart Valve Breakdown Data by Company
    • 7.2 European Union Tissue Engineered Heart Valve Breakdown Data by Type
    • 7.3 European Union Tissue Engineered Heart Valve Breakdown Data by Application

    8 China

    • 8.1 China Tissue Engineered Heart Valve Breakdown Data by Company
    • 8.2 China Tissue Engineered Heart Valve Breakdown Data by Type
    • 8.3 China Tissue Engineered Heart Valve Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Tissue Engineered Heart Valve Breakdown Data by Company
    • 9.2 Rest of World Tissue Engineered Heart Valve Breakdown Data by Type
    • 9.3 Rest of World Tissue Engineered Heart Valve Breakdown Data by Application
    • 9.4 Rest of World Tissue Engineered Heart Valve Breakdown Data by Countries
      • 9.4.1 Rest of World Tissue Engineered Heart Valve Sales by Countries
      • 9.4.2 Rest of World Tissue Engineered Heart Valve Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Medtronic
      • 10.1.1 Medtronic Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Tissue Engineered Heart Valve
      • 10.1.4 Tissue Engineered Heart Valve Product Introduction
      • 10.1.5 Medtronic Recent Development
    • 10.2 Edwards Lifesciences Corporation
      • 10.2.1 Edwards Lifesciences Corporation Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Tissue Engineered Heart Valve
      • 10.2.4 Tissue Engineered Heart Valve Product Introduction
      • 10.2.5 Edwards Lifesciences Corporation Recent Development
    • 10.3 Boston Scientific
      • 10.3.1 Boston Scientific Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Tissue Engineered Heart Valve
      • 10.3.4 Tissue Engineered Heart Valve Product Introduction
      • 10.3.5 Boston Scientific Recent Development
    • 10.4 St. Jude Medical
      • 10.4.1 St. Jude Medical Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Tissue Engineered Heart Valve
      • 10.4.4 Tissue Engineered Heart Valve Product Introduction
      • 10.4.5 St. Jude Medical Recent Development
    • 10.5 LivaNova PLC
      • 10.5.1 LivaNova PLC Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Tissue Engineered Heart Valve
      • 10.5.4 Tissue Engineered Heart Valve Product Introduction
      • 10.5.5 LivaNova PLC Recent Development
    • 10.6 Symetis SA
      • 10.6.1 Symetis SA Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Tissue Engineered Heart Valve
      • 10.6.4 Tissue Engineered Heart Valve Product Introduction
      • 10.6.5 Symetis SA Recent Development
    • 10.7 CryoLife
      • 10.7.1 CryoLife Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Tissue Engineered Heart Valve
      • 10.7.4 Tissue Engineered Heart Valve Product Introduction
      • 10.7.5 CryoLife Recent Development
    • 10.8 TTK Healthcare Limited
      • 10.8.1 TTK Healthcare Limited Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Tissue Engineered Heart Valve
      • 10.8.4 Tissue Engineered Heart Valve Product Introduction
      • 10.8.5 TTK Healthcare Limited Recent Development
    • 10.9 Colibri Heart Valve
      • 10.9.1 Colibri Heart Valve Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Tissue Engineered Heart Valve
      • 10.9.4 Tissue Engineered Heart Valve Product Introduction
      • 10.9.5 Colibri Heart Valve Recent Development
    • 10.10 Lepu Medical Technology
      • 10.10.1 Lepu Medical Technology Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Tissue Engineered Heart Valve
      • 10.10.4 Tissue Engineered Heart Valve Product Introduction
      • 10.10.5 Lepu Medical Technology Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Tissue Engineered Heart Valve Sales Channels
      • 11.2.2 Tissue Engineered Heart Valve Distributors
    • 11.3 Tissue Engineered Heart Valve Customers

    12 Market Forecast

    • 12.1 Global Tissue Engineered Heart Valve Sales and Revenue Forecast 2019-2025
    • 12.2 Global Tissue Engineered Heart Valve Sales Forecast by Type
    • 12.3 Global Tissue Engineered Heart Valve Sales Forecast by Application
    • 12.4 Tissue Engineered Heart Valve Forecast by Regions
      • 12.4.1 Global Tissue Engineered Heart Valve Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Tissue Engineered Heart Valve Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Tissue Engineered Heart Valve is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Tissue Engineered Heart Valve.

      This report studies the global market size of Tissue Engineered Heart Valve, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Tissue Engineered Heart Valve sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Medtronic
      Edwards Lifesciences Corporation
      Boston Scientific
      St. Jude Medical
      LivaNova PLC
      Symetis SA
      CryoLife
      TTK Healthcare Limited
      Colibri Heart Valve
      Lepu Medical Technology

      Market Segment by Product Type
      Transcatheter Heart Valves
      Tissue Heart Valves
      Mechanical Heart Valves

      Market Segment by Application
      Heart Surgery
      Cardiovascular Disease
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Tissue Engineered Heart Valve status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Tissue Engineered Heart Valve manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Tissue Engineered Heart Valve are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now